To do this, we first identified a PD-1 pathway inhibitor-insensitive murine tumor model which we found after implanting the kidney RENCA cell line orthotopically into BALB/c mice (Mosely et al, 2017) and treating with αPD-L1 or IgG antibody (Fig. 1J). The gene discussed is PDCD1; the disease is neoplasm.